NIH-funded research R01 grant

Understanding how a specific protein modification affects intellectual disability in males

Official title: The Role of the O-GlcNAc Modification in X-linked Intellectual Disability

Funded at University of Georgia · NIH-11034104 · Data updated 2026-11-12

This study is looking at how changes in a specific protein related to X-linked intellectual disability (which affects some boys) might help us find new ways to treat this condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Georgia
NIH-funded
Lab location1 site (Athens, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$370,713
NIH project number5R01HD110099-03
Project IDNIH-11034104 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are males diagnosed with X-linked intellectual disability, particularly those with identified mutations in the OGT gene.

Less likely to help

Patients with intellectual disabilities not linked to X-linked genetic factors or those without OGT mutations may not benefit from this research.

What this research studies

This research investigates the role of a protein modification called O-GlcNAc in X-linked intellectual disability (XLID), which affects about 1 in 500 males. The study focuses on unique mutations in the gene responsible for O-GlcNAc transferase (OGT) that lead to changes in the protein's structure and function. By using advanced techniques like Cas9-engineered stem cells and isotope-based approaches, researchers aim to understand how these mutations impact protein interactions and cellular processes. This knowledge could help identify new therapeutic targets for XLID.

Why it matters

Potential benefit: If successful, this research could lead to new treatments or interventions for individuals with X-linked intellectual disability.

How similar studies have gone: Previous research has shown promising results in understanding the role of protein modifications in various diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Georgia
    Athens, United States
    Active

Researchers

  • Principal investigator: Wells, Lance — University of Georgia
  • Study coordinator: Wells, Lance

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.